Ten years results of the Canadian breast intensity modulated radiation therapy (IMRT) randomized controlled trial

Radiotherapy and Oncology

Volumn 121, Issue 3, 2016, Pages 414-419

  Pignol, Jean Philippe ^a   Truong, Pauline ^b   Rakovitch, Eileen ^c   Sattler, Margriet G ^a   Whelan, Timothy J ^d   Olivotto, Ivo A ^e  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b Vancouver Island Cancer Centre   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d JURAVINSKI CANCER CENTRE   (Canada)

^e TOM BAKER CANCER CENTRE   (Canada)

Author keywords

Breast; Clinical trial; IMRT

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BENTZEN SCALE; BREAST CANCER TREATMENT OUTCOME SCALE; BREAST CARCINOMA; CANADA; CHRONIC PAIN; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DESQUAMATION; DISEASE FREE SURVIVAL; DOUBLE BLIND PROCEDURE; ESTHETICS; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MASTALGIA; MCGILL PAIN QUESTIONNAIRE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE QUESTIONNAIRE 30; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SKIN FIBROSIS; TELANGIECTASIA; UNIVARIATE ANALYSIS; VISUAL ANALOG SCALE; ACUTE DISEASE; ADVERSE EFFECTS; BREAST NEOPLASMS; CLINICAL TRIAL; MIDDLE AGED; PATHOLOGY; PROCEDURES; RADIATION INJURIES; RADIOMETRY; TELANGIECTASIS; VERY ELDERLY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CHRONIC PAIN; DOUBLE-BLIND METHOD; ESTHETICS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RADIATION INJURIES; RADIOMETRY; RADIOTHERAPY, INTENSITY-MODULATED; TELANGIECTASIS;

EID: 84994884931     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2016.08.021     Document Type: Article

References (26)

1. [1] Nyström, L., Andersson, I., Bjurstam, N., Frisell, J., Nordenskjöld, B., Rutqvist, L.E., Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 359 (2002), 909–919.
2. [2] Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby, S., McGale, P., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 378 (2011), 1707–1716.
3. [3] Clark, R.M., Whelan, T., Levine, M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88 (1996), 1659–1664.
4. [4] Fisher, B., Anderson, S., Bryant, J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002), 1233–1241.
5. [5] Veronesi, U., Cascinelli, N., Mariani, L., et al. Twenty-year follow-up of a randomized study compa ring breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002), 1227–1232.
6. [6] Lilla, C., Ambrosone, C.B., Kropp, S., et al. Predictive factors of late normal tissue complications following radiotherapy for breast cancer. Breast Ca Res Treat 106 (2007), 143–150.
7. [7] Amichetti, M., Caffo, O., Pain after quadrantectomy and radiotherapy for early-stage breast cancer: incidence, characteristics and influence on quality of life. Oncology 65 (2003), 23–28.
8. [8] Peuckmann, V., Ekholm, O., Rasmussen, N.K., et al. Chronic pain and other sequelae in long-term breast cancer survivors: nationwide survey in Denmark. Eur J Pain 13 (2009), 478–485.
9. [9] Pignol, J.P., Olivotto, I., Rakovitch, E., et al. A Phase III multicentre clinical trial of Breast Intensity Modulated Radiation Therapy (IMRT) to reduce skin radiation side effects. J Clin Oncol 26 (2008), 2085–2092.
10. [10] Kachnic, L.A., Powell, S.N., IMRT for breast cancer – balancing outcomes, patient selection, and resource utilization. J Natl Cancer Inst 103 (2011), 777–779.
11. [11] http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf, accessed on April 11th, 2016.
12. [12] Breivik, E.K., Bjornsson, G.A., Skovlund, E., A comparison of pain rating scales by sampling from clinical trial data. Clin J Pain 16 (2000), 22–28.
13. [13] Dworkin, R.H., Turk, D.C., Revicki, D.A., et al. Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain 144 (2009), 35–42.
14. [14] Stanton, A.L., Krishnan, L., Collins, C.A., Form or function? Part 1. Subjective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer 91 (2001), 2273–2281.
15. [15] Aaronson, N.K., Bartelink, H., van Dongen, J.A., van Dam, F.S., Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives. Eur J Surg Oncol 14 (1998), 133–140.
16. [16] RTOG/EORTC, Late effect consensus conference. RTOG/EORTC. Radiother Oncol 35 (1995), 5–7.
17. [17] Bentzen, S.M., Overgaard, M., Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radioth Oncol 20 (1991), 159–165.
18. [18] Aaronson, N.K., Ahmedzai, S., Bergman, B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993), 365–376.
19. [19] Sprangers, M.A., Groenvold, M., Arraras, J.I., et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study. J Clin Oncol 14 (1996), 2756–2768.
20. [20] Caffo, O., Amichetti, M., Ferro, A., Lucenti, A., Valduga, F., Galligioni, E., Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat 80 (2003), 39–48.
21. [21] Donovan, E., Bleakley, N., Denholm, E., et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 82 (2007), 254–264.
22. [22] Barnett, G.C., Wilkinson, J.S., Moody, A.M., et al. Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years. Int J Radiat Oncol Biol Phys 82 (2012), 715–723.
23. [23] Mukesh, M.B., Barnett, G.C., Wilkinson, J.S., et al. Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis. J Clin Oncol 31 (2013), 4488–4495.
24. [24] Mak, K.S., Chen, Y.H., Catalano, P.J., et al. Dosimetric inhomogeneity predicts for long-term breast pain after breast-conserving therapy. Int J Radiat Oncol Biol Phys 93 (2015), 1087–1095.
25. [25] Mukesh, M.B., Qian, W., Wilkinson, J.S., et al. Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial. Radiother Oncol 111 (2014), 270–275.
26. [26] Lundstedt, D., Gustafsson, M., Steineck, G., et al. Risk factors of developing long-lasting breast pain after breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 83 (2012), 71–78.